Four discussion sessions to help the 4th global precision medical (China) summit in 2019

Four discussion sessions to help the 4th global precision medicine (China) summit 2019 four discussion sessions to help precision medicine November 30-December 1, 2019 Wanli Hotel, longzhimeng, Shanghai From November 30 to December 1, more than 1000 precision medical industry participants attended the conference, gathering experts and scholars, top executives of global precision medical leaders, capital tycoons, etc., to talk about the clinical and industrial progress of global precision medicine, deliver cutting-edge scientific research results, and monitor industrial innovation Activity flow of organization: from the afternoon of November 29 to the morning of November 30, sign in meeting of leaders of precision medicine; from the afternoon of November 30, 2019 cancer precision treatment and health management meeting, 2019 reproductive health and birth defects prevention and control meeting; from December 1, 2019 in vitro diagnosis and precision medicine meeting, 2019 cell therapy industry innovation meeting, general meeting: leaders of precision Medicine Forum On November 30, two major clinical application scenarios of precision medicine discussed the conference of tumor precision treatment and health management ➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤ Coo ➤ tumor slows down and whole course management mode of burn stone medicine ➤ tumor classification, differential diagnosis, prognosis and medication guidance based on methylation detection of tumor tissue Zhang Aiguo CEO of Nanjing Diji Biotechnology Co., Ltd ➤ clinical application of tumor immunotherapy and immunocell therapy in malignant solid tumor ➤ integrated data statistics helps ctdna-ngs transform medical research personalized needs; Nanjing Kingsway Biotechnology Co., Ltd reserves a speech seat ➤ in the era of precision medicine, precision diagnosis and treatment of cardiovascular diseases, consultant expert of hypertension center of Fuwai Cardiovascular Hospital, Chinese Academy of Medical Sciences, and deputy director of National Key Laboratory of cardiovascular diseases Reproductive health and birth defects prevention and Control Conference ➤ reproductive genetics and birth defects prevention and control under precision medicine ➤ Xu Chenming director of reproductive genetics Department of International Peace Maternal and child health school affiliated to Shanghai Jiaotong University School of medicine ➤ clinical application of ctDNA in precise diagnosis of ovarian cancer ➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤ Illumina senior marketing manager of genetic and reproductive market in Greater China ➤ genetic solution throughout the fertility cycle ➤ chief information officer of duyang anouta gene technology (Beijing) Co., Ltd ➤ WGS clinical application research and expert consensus interpretation of undiagnosed children's genetic diseases Lin Senyong, deputy director of pediatric endocrinology / genetics Department of Xinhua Hospital Affiliated to Shanghai Jiaotong University Medical College and director of molecular diagnosis platform of Shanghai Institute of Pediatrics, on December 1, the conference on in vitro diagnosis and precision medicine of two rapid development boosters of precision medicine, interpretation of medical device registration system and supervision and management of in vitro diagnostic reagents Director of medical device supervision department of Shanghai food and Drug Administration ➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤ Suzhou Ruixun biological ➤ high-throughput sequencing to help tumor precise treatment general manager of luofangnuohe cancer business department ➤ Wuhan youzhiyou biotechnology reserved speech seat ➤ clinical molecular diagnosis application progress and quality management issues thinking Xiao Yanqun director of clinical cytomolecular genetics research room and molecular pathology research room of Shanghai Clinical Laboratory ➤ application of nucleic acid mass spectrometry technology in precision medicine; vice president of Jiangtang Dean Diagnostic Technology Group Co., Ltd., CTO, CSO ➤ guidance of pharmacogenomics; Zhang Wei, vice director of Clinical Pharmacology Research Institute of Xiangya Hospital, Central South University ➤ cleanplex ® - crossing the gap of targeted sequencing technology; Liu Zhidong, founder of Paragon genomics; reserved speech seat in Nanxiang Park ➤➤➤➤➤➤➤➤➤➤clinical application of non-invasive circulating tumor DNA detection Zhang Xiaochun Vice president of Affiliated Hospital of Qingdao University, senior scientist of MDAnderson cancer center cell therapy Industry Innovation Conference ➤ car-t cell therapy: pre clinical safety evaluation concerns and challenges Director of biotherapy center of Beijing hospital ➤ the current challenges and perspectives of cardimmuno therapy ➤ founder of Yu leiyoukadi ➤ reserved speech seat of telmogibist medical products trading (Shanghai) Co., Ltd ➤ research and Thinking on cell therapy of solid tumors ➤ chairman and CEO of LiZong haikeji biomedical (Shanghai) Co., Ltd ➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤➤ Fan Xiaohu, chief scientist of Nanjing legend Biotechnology Co., Ltd ➤ new progress of car-t in the treatment of blood tumors Liang aibin, vice president of Tongji Hospital Affiliated to Tongji University ➤ new strategy helps the research and development of cart Liu Yalong, research and development director of Shanghai Hengrun Dasheng Biotechnology Co., Ltd ➤ interactive round table discussion: seize the opportunity to promote the industrialization process of cell therapy in China Overseas experience in the production, listing, pricing and commercialization of medical insurance of cell therapy products refers to the development prospect of China's cell therapy industry sun Wenjun, vice president of business development of yaomingjunuo fan Xiaohu, chief scientist he Ting of Nanjing legend Biotechnology Co., Ltd., general manager and chairman of Beijing Yimiao Shenzhou medical technology Co., Ltd Lu Lu, Lu Lu Lu, Qi Fei, CEO of Heyuan Biotechnology (Tianjin) Co., Ltd., Liu Yun, investment director of Junlian capital, Liu Yun, founding partner of Huayi capital and only the last six seats in the ticket booth map of the chairman's meeting, contact us to provide multiple exhibition opportunities for the enterprise, including sponsorship, conference support, exhibition, journal advertisement, etc for details, please contact Ms Mavis Li Email: mavisli@healife.com Tel: 15502124800 contact: Ms Susanna Zhang email: susanazhang@healife.com Tel: 18117543710